Loading…
Lobbying Spend
—
Filings
3
Firms Hired
1
Active Period
2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
Client expense: — · Firm income: $150,000
Matched citations: H.R.9102
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
Client expense: — · Firm income: $150,000
Matched citations: H.R.9102
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
Client expense: — · Firm income: $150,000
Matched citations: H.R.9102
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
Client expense: — · Firm income: $150,000
Matched citations: H.R.9102
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
Client expense: — · Firm income: $150,000
Matched citations: S.5316
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
Client expense: — · Firm income: $150,000
Matched citations: S.5316
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
Client expense: — · Firm income: $150,000
Matched citations: S.5316
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
Client expense: — · Firm income: $150,000
Matched citations: S.5316
FY2027 Appropriations bills; H.R. 9102, Biotech Investment National Security Act of 2026.
Client expense: — · Firm income: $130,000
Matched citations: H.R. 9102
FY2027 Appropriations bills; H.R. 9102, Biotech Investment National Security Act of 2026.
Client expense: — · Firm income: $130,000
Matched citations: H.R. 9102
FY2027 Appropriations bills; H.R. 9102, Biotech Investment National Security Act of 2026.
Client expense: — · Firm income: $130,000
Matched citations: H.R. 9102
FY2027 Appropriations bills; H.R. 9102, Biotech Investment National Security Act of 2026.
Client expense: — · Firm income: $130,000
Matched citations: H.R. 9102
Source: Senate LDA